SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-009088
Filing Date
2020-05-15
Accepted
2020-05-15 16:01:56
Documents
52
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 617959
2 ex31-1.htm EX-31.1 11909
3 ex31-2.htm EX-31.2 11927
4 ex32-1.htm EX-32.1 7664
5 ex32-2.htm EX-32.2 7584
  Complete submission text file 0001493152-20-009088.txt   2581817

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE ogen-20200331.xml EX-101.INS 309759
7 XBRL SCHEMA FILE ogen-20200331.xsd EX-101.SCH 42487
8 XBRL CALCULATION FILE ogen-20200331_cal.xml EX-101.CAL 37366
9 XBRL DEFINITION FILE ogen-20200331_def.xml EX-101.DEF 100037
10 XBRL LABEL FILE ogen-20200331_lab.xml EX-101.LAB 267816
11 XBRL PRESENTATION FILE ogen-20200331_pre.xml EX-101.PRE 178786
Mailing Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634
Business Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

IRS No.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32188 | Film No.: 20884842
SIC: 2834 Pharmaceutical Preparations